This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US
September 23-26, 2024
Hynes Convention CenterBoston, MA

Timothy Nelson, MD, PhD
Founder & CEO at HeartWorks


As a physician/scientist trained in medicine and cardiac developmental biology, I have been driven to innovate with available technology with the goal of new product development. Congenital heart disease provides the optimal mix of challenges and opportunities to allow cross-functional teams to succeed and grow a whole new industry. The industry is the sustainable and growing academic research fueled by impact philanthropy that can de-risk product development and enable corporate-partners to provide the lowest-cost solutions to medical institutions- patients benefit and purpose-built team expand. Our Purpose is to inspire biomedical innovation teams and solve real-world medical problems with a focus on products that will obsolete the traditional processes that define yesterday’s healthcare experience.

Agenda Sessions

  • Keynote: Advancing Regenerative Medicine with Autologous Induced Pluripotent Stem Cell (iPSC)-derived Therapies